<unk>  was a COVID-19 vaccine candidate developed by the University of Queensland and the Australian pharmaceutical company CSL Limited. The vaccine candidate used the University of Queensland's molecular clamp technology and the MF59 adjuvant.
V451 vaccine
MMR vaccine
MMRV vaccine
RVSV-ZEBOV vaccine
Malaria vaccine
DTaP-IPV vaccine
Genetic vaccine
DTaP-IPV-HepB vaccine